Health Care
Commentary
The FDA’s waiting game is costing children’s lives
This week, Pfizer-BioNTech submitted data to the Food and Drug Administration demonstrating the safety and effectiveness of its COVID-19 vaccine in children ages 5 to 11. The duo is expected to apply for emergency-use authorization in the coming weeks. Federal regulators have promised they’ll “urgently” review the data. The FDA’s ...
Commentary
Drug Price Controls Inflict Worse Harm Than Even Critics Recognize
It’s no secret that H.R. 3 — the Democrats’ plan to impose price controls on prescription drugs — would have devastating consequences for our healthcare sector. After all, artificially restricting the price of any product invariably leads to shortages, rationing, and a slowdown in both investment and innovation. A new ...
Commentary
We Should Not Lose Sight of the Upcoming Flu Season
As the Food and Drug Administration contemplates booster shots and a myriad of other regulatory issues related to the COVID-19 vaccine, it is essential to reiterate the importance of a vaccine that is available and recommended for every age group at no cost to the patient — the influenza vaccine. ...
Commentary
As Democrats Push Single-Payer, Brits Hope To Escape It
A record 5.6 million patients in the United Kingdom are currently on waiting lists for hospital care. That’s equivalent to nearly one in 10 Britons. Of that group, about 300,000 have been waiting at least one year for treatment. Those who can afford to are increasingly paying out of pocket for private care. More than ...
Blog
30 Million Real Men Don’t Have Jobs
I recently read an eye-popping article by business writer Andy Serwer, who reported that nearly one-third of working-age men in America “aren’t doing diddly squat. They don’t have a job, and they aren’t looking for one either.” All total, that’s nearly 30 million men. “How do they live? What are ...
Blog
Crowdsourcing: A Revolutionary Solution to Health Care Price Transparency
On January 1st, 2021, the Centers for Medicare and Medicaid gifted the American people with a new rule requiring price transparency in healthcare. The federal rule requires hospitals to publish cash prices, prices with insurance plans, and minimum/maximum commercial negotiated prices in a “manner that is consumer-friendly,” each year. If ...
Commentary
Slow FDA approvals of at-home rapid tests have prolonged the pandemic
The delta variant has wreaked havoc. This week, the U.S. reported a seven-day average of more than 146,000 daily cases . In total, COVID-19 has killed more than 660,000 Americans since the start of the pandemic. Thankfully, the rate of increase appears to be falling in many areas, compared to ...
Commentary
Biden’s Prescription Drug Plan Is Nothing More Than Price Controls
The Biden administration’s “Comprehensive Plan for Addressing High Drug Prices,” released last week, paints a vivid picture of the difficulties patients face affording their medicines. “Americans pay too much for prescription drugs,” the report notes. “Many Americans do not take medications as prescribed because of their cost.” How does the administration intend to ...
Featured
Watch: PRI Expert Discusses Biden Prescription Drug Plan
Watch Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, discuss how the Biden plan to lower prescription drug costs is disappointing and would lead to less access and higher costs for patients with Scripps National News.
Commentary
Another Warning About Medicare Is Going Unheeded
The annual report from Medicare’s trustees just arrived. The picture it paints is anything but sunny. According to the report, Medicare’s Part A hospital insurance trust fund is set to be exhausted in 2026. Avoiding this fate, the trustees conclude, will require a massive increase in taxes or decrease in ...
The FDA’s waiting game is costing children’s lives
This week, Pfizer-BioNTech submitted data to the Food and Drug Administration demonstrating the safety and effectiveness of its COVID-19 vaccine in children ages 5 to 11. The duo is expected to apply for emergency-use authorization in the coming weeks. Federal regulators have promised they’ll “urgently” review the data. The FDA’s ...
Drug Price Controls Inflict Worse Harm Than Even Critics Recognize
It’s no secret that H.R. 3 — the Democrats’ plan to impose price controls on prescription drugs — would have devastating consequences for our healthcare sector. After all, artificially restricting the price of any product invariably leads to shortages, rationing, and a slowdown in both investment and innovation. A new ...
We Should Not Lose Sight of the Upcoming Flu Season
As the Food and Drug Administration contemplates booster shots and a myriad of other regulatory issues related to the COVID-19 vaccine, it is essential to reiterate the importance of a vaccine that is available and recommended for every age group at no cost to the patient — the influenza vaccine. ...
As Democrats Push Single-Payer, Brits Hope To Escape It
A record 5.6 million patients in the United Kingdom are currently on waiting lists for hospital care. That’s equivalent to nearly one in 10 Britons. Of that group, about 300,000 have been waiting at least one year for treatment. Those who can afford to are increasingly paying out of pocket for private care. More than ...
30 Million Real Men Don’t Have Jobs
I recently read an eye-popping article by business writer Andy Serwer, who reported that nearly one-third of working-age men in America “aren’t doing diddly squat. They don’t have a job, and they aren’t looking for one either.” All total, that’s nearly 30 million men. “How do they live? What are ...
Crowdsourcing: A Revolutionary Solution to Health Care Price Transparency
On January 1st, 2021, the Centers for Medicare and Medicaid gifted the American people with a new rule requiring price transparency in healthcare. The federal rule requires hospitals to publish cash prices, prices with insurance plans, and minimum/maximum commercial negotiated prices in a “manner that is consumer-friendly,” each year. If ...
Slow FDA approvals of at-home rapid tests have prolonged the pandemic
The delta variant has wreaked havoc. This week, the U.S. reported a seven-day average of more than 146,000 daily cases . In total, COVID-19 has killed more than 660,000 Americans since the start of the pandemic. Thankfully, the rate of increase appears to be falling in many areas, compared to ...
Biden’s Prescription Drug Plan Is Nothing More Than Price Controls
The Biden administration’s “Comprehensive Plan for Addressing High Drug Prices,” released last week, paints a vivid picture of the difficulties patients face affording their medicines. “Americans pay too much for prescription drugs,” the report notes. “Many Americans do not take medications as prescribed because of their cost.” How does the administration intend to ...
Watch: PRI Expert Discusses Biden Prescription Drug Plan
Watch Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, discuss how the Biden plan to lower prescription drug costs is disappointing and would lead to less access and higher costs for patients with Scripps National News.
Another Warning About Medicare Is Going Unheeded
The annual report from Medicare’s trustees just arrived. The picture it paints is anything but sunny. According to the report, Medicare’s Part A hospital insurance trust fund is set to be exhausted in 2026. Avoiding this fate, the trustees conclude, will require a massive increase in taxes or decrease in ...
